Enfermedad de Alzheimer y otros trastornos cognitivos
Publicaciones destacadas
-
α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment
Esteller-Gauxax, Diana; Perez Millan, Agnes; Sarto, Jordi; Puey, Roger; Guillen Soley, Nuria;(...)Auge Fradera, Josep Maria; Antonell, Anna; Sanchez-Valle, Raquel; Llado, Albert; Balasa, Mircea.Referencia:Neurology 2025.
-
Blood-based biomarkers for Alzheimer's disease: Positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology
Suarez-Calvet, M; Abdelnour, C; Alcolea, D; Mendioroz-Iriarte, M; Balasa, M;Morenas-Rodriguez, E; Puig-Pijoan, A; Sanchez-Juan, P; Villarejo-Galende, A; Sanchez-Valle, R.Referencia:Neurologia 2025.
-
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Bateman, Randall J; Li, Yan; McDade, Eric M; Llibre-Guerra, Jorge J; Clifford, David B;(...)Levin, Johannes; Lopera, Francisco; Roh, JeeHoon; Rosa-Neto, Pedro; Schofield, Peter R.Referencia:Lancet Neurology 2025.
-
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study
Tort-Merino, Adria; Perez-Millan, Agnes; Falgas, Neus; Borrego-ecija, Sergi; Esteller, Diana;(...)Illan-Gala, Ignacio; Balasa, Mircea; Llado, Albert; Rami, Lorena; Sanchez-Valle, Raquel.Referencia:Alzheimers & Dementia 2025.
-
Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia
Borrego-Ecija, Sergi; Junca-Parella, Jordi; Vandebergh, Marijne; Millan, Agnes Perez; Balasa, Mircea;(...)Moreno, Fermin; Borroni, Barbara; Rademakers, Rosa; Rohrer, Jonathan Daniel; Sanchez-Valle, Raquel.Referencia:Neurology 2024.
-
Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome
Carmona-Iragui, Maria; O 'Connor, Antoinette; Llibre-Guerra, Jorge; Lao, Patrick; Ashton, Nicholas J;Fortea, Juan; Sanchez-Valle, Raquel.Referencia:Ebiomedicine 2024.
-
Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's disease
Falgas, Neus; Pena-Gonzalez, Marta; Val-Guardiola, Andrea; Perez-Millan, Agnes; Guillen, Nuria;(...)Morales-Ruiz, Manuel; Bargallo, Nuria; Munoz-Moreno, Emma; Grinberg, Lea T; Sanchez-Valle, Raquel.Referencia:Alzheimers & Dementia 2024.
-
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity
Borrego-Ecija, Sergi; Perez-Millan, Agnes; Antonell, Anna; Fort-Aznar, Laura; Kaya-Tilki, Elif;(...)Vitorica, Javier; Luis Venero, Jose; Deierborg, Tomas; Boza-Serrano, Antonio; Sanchez-Valle, Raquel.Referencia:Alzheimers & Dementia 2024.
-
Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects
Rami, Lorena; Leon, Maria; Valech, Natalia; Coll-Padros, Nina; Bosch, Beatriz;(...)Salinero, Ana; Perez-Millan, Agnes; Molinuevo, Jose Luis; Sanchez-Valle, Raquel; Tort-Merino, Adria.Referencia:Neuropsychology 2023.
-
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data
Perez-Millan, Agnes; Contador, Jose; Junca-Parella, Jordi; Bosch, Beatriz; Borrell, Laia;(...)Rami, Lorena; Balasa, Mircea; Llado, Albert; Sanchez-Valle, Raquel; Sala-Llonch, Roser.Referencia:Human Brain Mapping 2023.
